Glen Industries P/B Ratio
Current P/B Ratio
2.12
Moderate Valuation
High - Premium to book value, growth expectations or asset-light model
Glen Industries (GLEN) P/B ratio is 2.12 (Moderate), book value per share ₹43.75 vs Healthcare average P/B of -0.01 — High - Premium to book value, growth expectations or asset-light model. Also explore Glen Industries stock price data download to track price trends across different timeframes.
Current Valuation Metrics
P/B Ratio
2.12
Current Price
₹
Book Value/Share
₹43.75
Exchange
None
Book Value Breakdown (2026)
Balance Sheet Components
Total Equity
₹140 Cr
Share Capital
₹32 Cr
Reserves & Surplus
₹107 Cr
Outstanding Shares
32,000,000
Book Value per Share
₹43.75
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
-0.01
Sector Median
0.62
Sector Rank
#11 of 50
Sector Percentile
22.0%
GLEN P/B Ratio — Valuation Insights & Book Value Analysis
Glen Industries price-to-book ratio interpretation, valuation status and historical context — current P/B 2.12 (Moderate). For live price, earnings yield and the full fundamental profile, see GLEN stock price BSE.
- Trading at premium to sector average PB of -0.01
GLEN vs Healthcare Peers — P/B Ratio Comparison
Glen Industries P/B 2.12 vs Healthcare average -0.01, median 0.62 — range -6.55–1.14.
Sector Average
-0.01
Sector Median
0.62
Lowest P/B
-6.55
Highest P/B
1.14
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.14 | ₹70 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.74 | ₹118 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.16 | ₹43 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |